icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
BHwza5pqDuNyFbVW
Listen
